Associate Professor Ling Yang
Research groups
- Assessment of the role of EBV infection in aetiology of nasopharyngeal and gastric cancers in Chinese adults CRUK STUDENTSHIP AVAILABLE
- Chronic infection, host immunity and risk of cancer (MRC PHRU)
- Chronic infection, host immunity, and non-communicable disease risk
- Chronic infection, host immunity, and disease risk
- Female reproductive history and risks of cancer and other diseases in a prospective cohort study of 300,000 Chinese women
- Genomic analysis of reproductive health in Chinese populations
- Reproductive factors and breast cancer risk in diverse populations
Ling Yang
PhD
Senior Epidemiologist
Ling is a senior epidemiologist at The Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) and the Medical Research Council Population Health Research Unit at the University of Oxford (MRC PHRU), and leads the long-term follow-up working group, women health and infection and cancer research groups in the China Kadoorie Biobank study (CKB).
Her main research focus are on women’s reproductive health, chronic infection and environmental causes of chronic diseases (especially cancer) based on large scale cohort studies, and evidence-based medicine using large national disease surveillance and risk factors survey data to provide strategies for chronic disease prevention and control in developing countries.
Before moving to the University of Oxford in 2007, Ling worked at the Chinese Academy of Medical Science (CAMS) and Ministry of Health in Beijing (China), WHO International Agency for Research on Cancer in Lyon (IARC/WHO, France) and Karolinska Institutet in Stockholm (Sweden).
Ling qualified in Medicine at South-Eastern University (China) in 1995 then gained her MSc in Bio-statistics in 1998 there, and her PhD in Epidemiology at the University of Tampere (Finland) in 2005.
Recent publications
-
Spirometric pattern and cardiovascular risk: a prospective study of 0.3 million Chinese never-smokers.
Ding Y. et al, (2025), Lancet Reg Health West Pac, 54
-
Adiposity and risks of gastrointestinal cancers: A 10-year prospective study of 0.5 million Chinese adults.
Chan WC. et al, (2024), Int J Cancer
-
Cost-Effectiveness of Salt Substitution and Antihypertensive Drug Treatment in Chinese Prehypertensive Adults.
Sun Z. et al, (2024), Hypertension, 81, 2529 - 2539
-
Early adulthood BMI and cardiovascular disease: a prospective cohort study from the China Kadoorie Biobank.
Chen Y. et al, (2024), Lancet Public Health, 9, e1005 - e1013
-
Proteo-genomic analyses in relatively lean Chinese adults identify proteins and pathways that affect general and central adiposity levels.
Iona A. et al, (2024), Commun Biol, 7